EP3019490
N,6-BIS(ARYL OR HETEROARYL)-1,3,5-TRIAZINE-2,4-DIAMINE COMPOUNDS AS IDH2 MUTANTS INHIBITORS FOR THE TREATMENT OF CANCER
:
EP einkaleyfi: Þýðing ekki lögð inn:
10.7.2014:
3.6.2020:
14745309.6
:
9.7.2034
:
N,6-BIS(ARYL OR HETEROARYL)-1,3,5-TRIAZINE-2,4-DIAMINE COMPOUNDS AS IDH2 MUTANTS INHIBITORS FOR THE TREATMENT OF CANCER
10.7.2014
3.6.2020
:
Agios Pharmaceuticals, Inc.:
88 Sidney Street, Cambridge, MA 02139, US
:
TRAVINS, Jeremy:
Southborough, MA 01772, US
:
UTLEY, Luke:
Milford, NH 03055, US
:
201361845352 P:
11.7.2013:
US
:
US2014046204:
10.7.2014
:
C07D 401/14, C07D 401/04, C07D 401/12, C07D 403/12, C07D 403/04, C07D 413/12, C07D 417/12, C07D 417/14, C07D 251/18, A61K 31/53, A61P 35/00